Archive for November, 2010

Zimmer NexGen® Knee Replacement Failures

November 2010

The Zimmer NexGen® knee replacement implant has been found to have a high rate of failure, loosening, pain and other issues / complications.

A surgeon and consultant to Zimmer Holdings called for a Zimmer NexGen® knee recall to be issued. The reason this action was taken was as result of repeated observation of problems, later to be followed by a study confirming the initial findings.

The model at issue, the NexGen® CR-Flex, is designed to provide a greater range of motion than the standard NexGen.

The most commonly used method of implanting an artificial knee is by using an adhesive to bond the thigh bone to the portion of the device that bends, cementing the two together. Some specialists avoid adhesives because cement can break down, causing failure of the device. Because of this, Zimmer sells an uncemented version of the CR-Flex that relies on the bone naturally growing into the implant. This uncemented version is the source of the problems and complaints.

“…he gave the device, which is supposed to last about 15 years, to about 125 patients in 2005, the first full year he used it. But by early 2006, some X-rays showed lines where the implant met the thigh bone, an indication that the device was loose and had not fused completely. Patients could walk, but they were reporting pain, apparently a result of the loose joint.”  – New York Times article titled “Surgeon vs. Knee Maker:  Who’s Rejecting Whom?” 18 June 2010

Several prominent surgeons, one the former consultant for Zimmer mentioned above, first presented their study at a medical meeting in the fall of 2009 and again this year at a national meeting of the American Association of Orthopedic Surgeons.

The uncemented Zimmer knee was found to fail in 9 percent of 100 patients featured in the study. Furthermore, the knee was observed to be loose in approximately 50% of the patients, requiring additional surgeries in some of the patients.

The Zimmer NexGen® CR-Flex Porous Femoral components are replacement knee products that have been associated with a high number of reports of:

•Loosening of Replacement Knees (50% in study mentioned above)
•Knee replacement failure
•Surgery required to correct complications
•Other knee complications and pain
If you or a loved one has been seriously injured after surgical implantation with any of the Zimmer NexGen® CR femoral components, please contact us immediately for a free consultation.

These problems could include:

•Unexplained pain following knee replacement
•Loosening of replacement knee
•Revision knee surgery to correct problems 

Who We Are
The Mulligan Law Firm, a national law firm located in Dallas, Texas, provides legal information and resources for injured individuals and their families. The firm has successfully resolved over $600,000,000 in claims for its clients. Formed in 1995, it has been helping people for almost 15 years, with the strength and experience to represent plaintiffs in all 50 states.

The Mulligan Law Firm is currently investigating injury claims involving Zimmer NexGen® Knee Replacements. 

If you or a loved one has been seriously injured after surgical implantation of a Zimmer NexGen® Knee Replacement, it is important that you consult with a legal professional immediately. The Mulligan Law Firm has experienced lawyers standing by to help you.

You may be entitled to compensation for your injuries. We take all cases on a contingency-fee basis, which means you do not pay for our services unless you receive an award or compensation.

Do not delay, as your rights and compensation may be lost forever if you wait.  Call us now at 866 529 0001, Extension 245, or simply fill a form out on this website.

Darvon® and Darvocet® Linked to Death, Heart Attacks, and Arrhythmia: California, Texas, Florida Lawyers Now Providing Free Potential Claim Evaluations

November 2010

Banned in the United Kingdom since 2005 and then the European Union in January 2009, an estimated 10 million patients have used these common painkillers.

On November 19, 2010 the FDA asked manufacturers of propoxyphene (Darvon®, Darvocet®) for a product recall. 

Propoxyphene is an opioid used to treat mild to moderate pain.  Approved by the FDA and available since 1957, propoxyphene is manufactured by Xanodyne Pharmaceuticals Inc., which markets the drug as Darvon® and Darvocet®. The difference between the two painkillers is that while Darvon® is composed entirely of propoxyphene, Darvocet® combines propoxyphene and acetaminophen.

Some of the other limitations of propoxyphene-containing medicines include:
·         As weak painkillers, they provide minimal benefits.
·         The combination of propoxyphene and acetaminophen (Darvocet®) is no more effective than acetaminophen on its own.
·         The difference between the dose needed for treatment and a harmful dose is too small, increasing the potential for overdose.
·         As an opioid, it is also addictive.

“The FDA is advising health care professionals to stop prescribing propoxyphene to their patients, and patients who are currently taking the drug should contact their health care professional as soon as possible to discuss switching to another pain management therapy.” – FDA News Release, November 19, 2010.

Severe and even fatal responses to Darvon® and other pain medications containing propoxyphene have been reported, such as:
Heart Attack
Heart Arrhythmia

If you or a loved one have experienced any side effects such as these from taking these medications, please contact us as soon as possible for a free potential claim evaluation.  Please fill a form out on this website or call our toll free number for additional information.   Always consult carefully with your doctor prior to stopping any medication.